Recruitment agencies are under constant pressure to move faster, present candidates professionally and reduce administrative ...

Eli Lilly and Company (NYSE:LLY) is one of the best stocks to buy now for long term growth. Eli Lilly and Company (NYSE:LLY) ...

Eli Lilly (LLY) just did something worth paying attention to. With CVS Caremark announcing coverage of both Zepbound and ...

A simple phone call left an Olathe woman in tears. An Overland Park painting company surprised Virginia Kasper by repainting her home for free after learning she couldn't afford the project.

CVS Caremark, one of America’s most powerful pharmacy benefit managers, will begin covering more GLP-1 medications again ...

(CNN)– CVS is adding two weight-loss options to its drug plans. CVS Health said it will start coverage of Lilly’s anti-obesity pill, June 1. And it’s reinstating coverage of Eli Lilly’s weight-loss ...

Despite a lack of regulation, we still have the ability to steer artificial intelligence in ways that can benefit our common humanity.

The pharmacy benefit manager dropped Zepbound a year ago in favor of rival Wegovy — now both Lilly and Novo Nordisk drugs ...

Zepbound’s preferred-tier reinstatement suggests improved net pricing and signals renewed willingness to broaden injectable anti-obesity access under commercial benefit designs. Lifting Foundayo’s ...

CVS Caremark is putting Eli Lilly’s obesity drug Zepbound back on some commercial formularies starting Oct. 1, reversing a mid-2025 decision that had nudged many patients toward rival GLP-1 ...

CVS Health will restore Eli Lilly's weight-loss injection Zepbound to its list of covered ‌drugs and add the drugmaker's ...

CVS Health will restore Eli Lilly’s weight-loss injection Zepbound to its list of covered drugs and also add the drugmaker’s ...